Germany has decided to approve the Oxford/AstraZeneca Covid-19 jab for people aged 65 and over, in a move that could help speed up the country’s sluggish vaccination campaign.
德国已决定批准65岁及以上人群接种牛津/阿斯利康(Oxford/AstraZeneca)的新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）疫苗，此举可能有助于加快该国进展缓慢的疫苗接种运动。
您已阅读12%（275字），剩余88%（2083字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。